AU2001244358A1 - Schizophrenia related genes - Google Patents

Schizophrenia related genes

Info

Publication number
AU2001244358A1
AU2001244358A1 AU2001244358A AU4435801A AU2001244358A1 AU 2001244358 A1 AU2001244358 A1 AU 2001244358A1 AU 2001244358 A AU2001244358 A AU 2001244358A AU 4435801 A AU4435801 A AU 4435801A AU 2001244358 A1 AU2001244358 A1 AU 2001244358A1
Authority
AU
Australia
Prior art keywords
related genes
schizophrenia related
schizophrenia
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244358A
Other languages
English (en)
Inventor
Susan Cochran
Brian Morris
Yoshitaka Ohashi
Gary Paterson
Judith Pratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0007880A external-priority patent/GB0007880D0/en
Priority claimed from GB0012768A external-priority patent/GB0012768D0/en
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU2001244358A1 publication Critical patent/AU2001244358A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
AU2001244358A 2000-03-31 2001-04-02 Schizophrenia related genes Abandoned AU2001244358A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0007880.8 2000-03-31
GB0007880A GB0007880D0 (en) 2000-03-31 2000-03-31 Schizophrenia related genes
GB0012768.8 2000-05-26
GB0012768A GB0012768D0 (en) 2000-05-26 2000-05-26 Schizophrenia related genes
PCT/GB2001/001486 WO2001075440A2 (en) 2000-03-31 2001-04-02 Schizophrenia related genes

Publications (1)

Publication Number Publication Date
AU2001244358A1 true AU2001244358A1 (en) 2001-10-15

Family

ID=26244008

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244358A Abandoned AU2001244358A1 (en) 2000-03-31 2001-04-02 Schizophrenia related genes

Country Status (5)

Country Link
US (2) US20030175741A1 (enExample)
EP (1) EP1356284A2 (enExample)
JP (1) JP2003531587A (enExample)
AU (1) AU2001244358A1 (enExample)
WO (1) WO2001075440A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3507884B2 (ja) * 2000-03-07 2004-03-15 新潟大学長 遺伝子発現を指標とする統合失調症の客観的診断法
WO2002029038A2 (en) * 2000-10-04 2002-04-11 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002033080A2 (en) * 2000-10-16 2002-04-25 Bayer Aktiengesellschaft Regulation of human netrin binding membrane receptor unc5h-1
WO2004007762A2 (en) * 2002-07-11 2004-01-22 Novartis Ag Genes associated with schizophrenia, adhd and bipolar disorders
JP2004135667A (ja) * 2002-09-27 2004-05-13 Japan Science & Technology Agency 血液を用いた統合失調症の診断方法
WO2004031235A1 (en) * 2002-10-07 2004-04-15 Bayer Healthcare Ag Regulation of human calcium-independent alpha-latrotoxin receptor
GB0712524D0 (en) * 2007-06-28 2007-08-08 Mitsubishi Pharma Corp Novel schizophrenia associated genes
US20110136738A1 (en) * 2008-02-15 2011-06-09 University College Dublin, National University Of Ireland, Dublin Alternatively Transcribed Genes Associated with Schizophrenia
US20110217240A1 (en) * 2008-09-03 2011-09-08 Craig Ferris Imaging neuroleptic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630345B2 (en) * 1997-03-04 2003-10-07 New York University Nucleic acids encoding a calcium independent receptor of α-latrotoxin, characterization and uses thereof
WO1999007739A2 (en) * 1997-08-06 1999-02-18 The Rockefeller University Dna encoding the human synapsin iii gene and uses thereof
JP3507884B2 (ja) * 2000-03-07 2004-03-15 新潟大学長 遺伝子発現を指標とする統合失調症の客観的診断法

Also Published As

Publication number Publication date
JP2003531587A (ja) 2003-10-28
WO2001075440A3 (en) 2003-04-24
WO2001075440A2 (en) 2001-10-11
EP1356284A2 (en) 2003-10-29
US20070074295A1 (en) 2007-03-29
US20030175741A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
WO2003018621A8 (en) Genes
AU2001244570A1 (en) Writing implement
AU2001233626A1 (en) Marker
AU2001278918A1 (en) Novel lipase genes
AU2001265089A1 (en) Rc-timer scheme
AU2001295795A1 (en) Streptococcal genes
AU2001242755A1 (en) Writing implement
AU2001227903A1 (en) Everninomicin biosynthetic genes
AU6277600A (en) Novel chimeric genes
AU2001244358A1 (en) Schizophrenia related genes
AU2001242625A1 (en) Gene sequence
AU2001240103A1 (en) Reproduction-specific genes
AU2001282149A1 (en) Improved marker
AU2001264247A1 (en) GASC1 gene
AU6424701A (en) Gasc1 gene
AU2376200A (en) Insulin-synthesis genes
AU2001288839A1 (en) Self-rearranging dna vectors
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU2003222965A1 (en) Schizophrenia associated genes
AU2001241080A1 (en) Mouse adipocyte-origin genes
AU2001278042A1 (en) Daz genes
AU2002221623A1 (en) Gene 4